Dennis L Sacdalan
Overview
Explore the profile of Dennis L Sacdalan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
34
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fernandez J, Borlongan M, Baliton M, Sacdalan D, Sy F, Agoncillo A, et al.
Acta Med Philipp
. 2025 Jan;
58(22):77-91.
PMID: 39817104
Background And Objective: Colorectal cancer (CRC) has the third highest incidence in the Philippines. Currently, there is a paucity in literature that is focused on the knowledge, attitudes, and perceptions...
2.
Fran M, Leano D, de Borja J, Uy C, Andresan A, Sacdalan D, et al.
Cells
. 2024 Oct;
13(20.
PMID: 39451209
NRAS belongs to the RAS family of GTPases. In colorectal cancer (CRC), NRAS mutations are rare compared to KRAS, but may lead to worse outcomes. We report the functional characterization...
3.
Co L, Dychiao R, Capistrano M, Tayag M, Ong E, Ho F, et al.
Ann Surg Oncol
. 2024 Aug;
31(12):7685-7687.
PMID: 39174838
No abstract available.
4.
Ting F, Uy C, Bebero K, Sacdalan D, Abarquez H, Nilo G, et al.
Ecancermedicalscience
. 2022 Sep;
16:1424.
PMID: 36158983
The Choosing Wisely Philippines campaign is an initiative that identifies low-value or potentially harmful practices that are relevant to patients with cancer in the Philippines. The main purpose of these...
5.
Eala M, Basilio P, Dee E, Cereno R, Ang C, Magsanoc N, et al.
Cancer Causes Control
. 2022 Jul;
33(10):1273-1275.
PMID: 35857181
In this Commentary, we discuss disparities in resources for and access to cancer trials from the perspective of the Philippines, a lower-middle-income country in Southeast Asia, where cancer is the...
6.
Puyat C, Eala M, Dee E, Tantengco O, Cruz A, Faylona E, et al.
Lancet Oncol
. 2022 Jan;
23(1):e2.
PMID: 34973227
No abstract available.
7.
Larrazabal R, Chiu H, Sacdalan D
BMJ Case Rep
. 2021 Aug;
14(8).
PMID: 34344650
A 28-year-old woman came for non-traumatic right flank pain with hypotension and right flank mass. She had multiple hyperpigmented skin papules located on the centre area of her face, and...
8.
Sacdalan D, Mendoza M, Vergara J, Catedral L, Ting F, Leones L, et al.
Med Oncol
. 2020 Nov;
37(11):106.
PMID: 33135102
Small bowel cancers are rare tumors with an incidence 50-100-fold less than colorectal cancer. These tumors carry a poor prognosis. Owing to its rarity, treatment of this disease, particularly in...
9.
Catedral L, Tan H, Chua Jr A, Sacdalan D, Sacdalan D
JCO Glob Oncol
. 2020 Oct;
6:1593-1608.
PMID: 33079606
Purpose: Several factors affect how medical oncologists in the Philippines use biomarkers in real-world practice. This study describes patterns of biomarker testing for the management of breast, colorectal, and lung...
10.
Mendoza M, Tan H, Hernandez A, Dala B, Sacdalan D, Sacdalan D, et al.
Ecancermedicalscience
. 2020 Jul;
14:1066.
PMID: 32728382
COVID-19 has abruptly and radically changed the landscape of cancer care delivery throughout the world, including the Philippines. The Philippine General Hospital is the academic hospital of the University of...